Clinical Trial Update: HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir [Phase 4]

View source ↗

Summary

Phase 4 study update examining HCV evolution in HIV/HCV coinfected patients (genotype 1) treated with Fosamprenavir. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• Fosamprenavir (fosamprenavir)

Snippet

Sponsor: Fundacion SEIMC-GESIDA | Conditions: Chronic HIV Infection, HCV Coinfection | Phase 4 | Status: COMPLETED